Glass House Brands Swaps Auditor Macias Gini for BDO USA
GLAS sits 54% above its 52-week low of $5.15 on elevated volume (2.0× avg).
Summary
Glass House Brands replaced auditor Macias Gini & O'Connell LLP with BDO USA, P.C., effective September 11, 2026, with no modified opinions or reportable events disclosed.
Key Events · Corporate Governance and Compliance · GLAS
-
Auditor Change Effective September 11
At the Company's request, Macias Gini & O'Connell LLP resigned and BDO USA, P.C. was appointed as successor auditor, effective September 11, 2026.
-
No Modified Opinion or Reportable Event
The predecessor auditor issued no modified opinion on the two most recently completed fiscal years, and the Board determined no reportable event occurred under NI 51-102.
-
Board and Audit Committee Approval
The resignation and appointment were considered and approved by the Company's audit committee and board of directors.
-
Regulatory Letters Filed
Both the predecessor and successor auditors furnished letters to Canadian securities administrators agreeing with the statements in the Notice of Change of Auditor.
Analysis · GLAS · Life Sciences
Effective September 11, 2026, Glass House Brands dismissed Macias Gini & O'Connell LLP and brought in BDO USA, P.C. as its new auditor. The filing notes that the predecessor auditor issued no modified opinion on the two most recently completed fiscal years and that no reportable event occurred under NI 51-102. While auditor changes can unsettle investors, the absence of any disagreement or modified opinion reduces the risk that this reflects an accounting dispute. The change was approved by the audit committee and board.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 30.2% of the 1943 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GLAS was trading at $7.93 on NYSE in the Life Sciences sector, with a market capitalization of approximately $614M. The 52-week trading range was $5.15 to $13.93. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.